NRX Pharmaceuticals
NRXP
NRXP
18 hedge funds and large institutions have $1.26M invested in NRX Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
42% less funds holding
Funds holding: 31 → 18 (-13)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Holders
18
Holding in Top 10
–
Calls
$212K
Puts
$131K
Top Buyers
| 1 | +$235K | |
| 2 | +$120K | |
| 3 | +$57.8K | |
| 4 |
VF
Virtu Financial
New York
|
+$42K |
| 5 |
State Street
Boston,
Massachusetts
|
+$12.9K |
Top Sellers
| 1 | -$89K | |
| 2 | -$57.9K | |
| 3 | -$35.4K | |
| 4 |
TCBWMS
Texas Capital Bank Wealth Management Services
Dallas,
Texas
|
-$29.9K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$20.6K |